Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers
Some advanced therapy medicinal products (ATMPs) hold great promises for life-threatening diseases with high unmet needs. However, ATMPs are also associated with significant challenges in market access, which necessitates the joint efforts between all relevant stakeholders to navigate. In this revie...
Saved in:
Main Authors: | Tingting Qiu (Author), Shuyao Liang (Author), Yitong Wang (Author), Claude Dussart (Author), Borislav Borissov (Author), Mondher Toumi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient-reported outcome claims in European and United States orphan drug approvals
by: Szymon Jarosławski, et al.
Published: (2018) -
Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
by: Szymon Jarosławski, et al.
Published: (2018) -
Gene therapy randomised clinical trials in Europe - a review paper of methodology and design
by: Krassimira Ilieva, et al.
Published: (2020) -
Why "American Patients First" is likely to raise drug prices outside of the United States
by: Monique Dabbous, et al.
Published: (2019) -
A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
by: Mondher Toumi, et al.
Published: (2020)